Quanterix Corporation
NASDAQ:QTRXMedical - Devices
+$0.46 today
- Market cap
- $98.28M
- Beta
- 1.12
- P/E (TTM)
- -1.5
- EPS (TTM)
- -$2.22
Volume 3.54M
Average 1.15M
QTRX Operating Income
Profit from core operations after operating expenses, before interest and taxes.
Quanterix CorporationNASDAQ: QTRX
Operating Income · Q1 FY2026 · quarter ended Mar 2026
Operating income remains negative
Q1 FY2026 operating income was -$21.53M, compared with -$26.37M a year earlier. Trailing-twelve-month operating income was -$119.82M.
Context
- Operating income amounted to 79.2% of revenue in FY2025, up 40.4 pp from a year earlier.
- Operating income grew in size in 2 of the last 3 fiscal years.
- FY2025 was the largest annual figure in the 4 fiscal years shown.
What to watch
Whether operating income reaches the consensus estimate from 2 analysts of -$96.99M (+11.7%) for the fiscal year ending Dec 2026, a step up from the -108.7% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterMar 2026
- -$21.53M+9.8% QoQ
- Last fiscal yearDec 2025
- -$109.82M-108.7% YoY
- LTMMar 2026
- -$119.82M-87.7% YoY
| Horizon | Past | Forecast | Difference |
|---|---|---|---|
| Quarter | +18.4% | +47.6% | +29.2 pp |
| 1 year | -108.7% | +11.7% | +120.4 pp |
| 3-year CAGR | — | — | — |
| 5-year CAGR | — | — | |
| 10-year CAGR | — | — |
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Operating Income history
USD · from the income statement
- Latest · FY2025
- (109.82M) USD
- Year-over-year change
- -108.7%
| Period | Period end | Operating Income | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | (109.82M) | -108.7% |
| FY2024 | 2024-12-31 | (52.62M) | -14.4% |
| FY2023 | 2023-12-31 | (45.99M) | +55.9% |
| FY2022 | 2022-12-31 | (104.26M) | -84.5% |
| FY2021 | 2021-12-31 | (56.52M) | — |
Operating Income vs competitors
How QTRX compares with its peers on the latest reported figures
- QTRX's LTM Mar 2026 operating income of -$119.82M is the lowest of the 11 companies compared; the peer median is -$42.82M.
- Its year-over-year change of -87.7% is the lowest of 11, against a peer median of +8.2%.
- Operating income amounts to 82.7% of revenue for QTRX, versus a peer median of 52.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $24.02M | +22.9% | +35.9% | 8.4% | |
| LTM Mar 2026 | $2.84M | -62.0% | — | 6.4% | |
| LTM Mar 2026 | -$30.35M | +52.8% | — | 52.5% | |
| LTM Mar 2026 | -$30.97M | +8.6% | — | 8.8% | |
| LTM Mar 2026 | -$35.65M | +28.2% | — | 44.8% | |
| LTM Mar 2026 | -$49.99M | +1.4% | — | 84.6% | |
| LTM Mar 2026 | -$59.23M | +7.8% | — | — | |
| LTM Dec 2025 | -$60.7M | -7.0% | — | 466.2% | |
| LTM Mar 2026 | -$66.94M | +27.9% | — | 56.9% | |
| LTM Mar 2026 | -$86.7M | -23.7% | — | 213.0% | |
| LTM Mar 2026 | -$119.82M | -87.7% | — | 82.7% | |
| Peer median (excluding QTRX) | -$42.82M | +8.2% | +35.9% | 52.5% | |
Competitors are the stored peer set for QTRX. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 110.56M | 105.52M | 121.14M | 135.44M | 138.65M |
| Cost of Revenue | 45.78M | 60.16M | 48.14M | 54.32M | 73.94M |
| Gross Profit | 64.77M | 45.36M | 73M | 81.12M | 64.72M |
| Gross Margin | 58.6% | 43.0% | 60.3% | 59.9% | 46.7% |
| Research & Development | 28.38M | 26.81M | 26.06M | 31.08M | 35.92M |
| Selling, General & Admin | 92.91M | 91.85M | 92.82M | 104.64M | 138.85M |
| Operating Expenses | 121.29M | 149.63M | 118.99M | 133.74M | 174.53M |
| Depreciation & Amortization | 4.88M | 5.41M | 8.29M | 8.36M | 18.93M |
| EBITDA | (50.3M) | (67.89M) | (36.37M) | (29.74M) | (93.35M) |
| EBITDA Margin | -45.5% | -64.3% | -30.0% | -22.0% | -67.3% |
| Operating Income | (56.52M) | (104.26M) | (45.99M) | (52.62M) | (109.82M) |
| Operating Margin | -51.1% | -98.8% | -38.0% | -38.8% | -79.2% |
| Interest Income | 0 | 5.13M | 15.84M | 14.66M | 8.57M |
| Interest Expense | 403K | 0 | 0 | 0 | 0 |
| Other Income / Expenses | 937K | 4.85M | 18.36M | 14.52M | (2.46M) |
| Income Before Tax | (55.58M) | (99.41M) | (27.64M) | (38.1M) | (112.27M) |
| Pre-Tax Margin | -50.3% | -94.2% | -22.8% | -28.1% | -81.0% |
| Income Tax Expense | (36K) | 164K | 719K | 434K | (5.12M) |
| Net Income | (55.55M) | (99.57M) | (28.35M) | (38.53M) | (107.15M) |
| Net Margin | -50.2% | -94.4% | -23.4% | -28.4% | -77.3% |
| EPS (Basic) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| EPS (Diluted) | (1.60) | (2.61) | (0.86) | (1.00) | (2.51) |
| Weighted Avg Shares | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
| Weighted Avg Shares (Diluted) | 36M | 36.99M | 37.59M | 38.37M | 42.64M |
Quanterix Corporation
NASDAQ:QTRX
Intrinsic Alpha fair value
Locked
Current Price
$2.07
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.